Background: Despite recognition that weight loss is a problem in elderly persons with probable Alzheimer's disease (AD), increasing their food intake remains a challenge. To effectively enhance intake, interventions must work with individuals' changing needs and intake patterns. Previously, the authors reported greater food consumption at breakfast, a high-carbohydrate meal, compared with dinner, and shifts toward carbohydrate preference at dinner in those with increased behavioral difficulties, low body mass index, or both.
Methods: Thirty-four nursing home residents with probable AD who ate independently participated in a randomized, crossover, nonblinded study of two nutrition interventions. The intervention described here included replacing 12 nonconsecutive "traditional" dinners with meals high in carbohydrate but comparable to traditional dinners in protein. Measures included weighed food intake, body weight, cognitive function (as assessed using the Severe Impairment Battery and Global Deterioration Scale), behavioral disturbances (as assessed using the Neuropsychiatric Inventory-Nursing Home Version), and behavioral function (as assessed using the London Psychogeriatric Rating Scale).
Results: Group mean dinner and 24-hour energy intake increased during the intervention phase compared with baseline, protein intake was unaffected, and carbohydrate intake increased. Increased dinner intake, attributable to intervention foods, was achieved in 20 of 32 of participants who completed the study and was associated with increased carbohydrate preference, poorer memory, and increased aberrant motor behavior. Those with low body mass indices were the most resistant to the intervention.
Conclusions: Providing a high-carbohydrate meal for dinner increases food intake in seniors at later stages of the disease who are experiencing cognitive and behavioral difficulties, possibly as a result of a shift in preference for high-carbohydrate foods.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/gerona/60.8.1039 | DOI Listing |
Viruses
December 2024
1st Internal Medicine Department, AHEPA University Hospital, School of Medicine, Aristotle University of Thessaloniki, 55436 Thessaloniki, Greece.
People with HIV (PWH) have an elevated risk of cardiovascular disease compared to those without HIV. This study aimed to investigate the relative serum expression of microRNAs (miRNAs) associated with arterial stiffness, a significant marker of cardiovascular disease. A total of 36 male PWH and 36 people without HIV, matched for age, body mass index, pack years, and dyslipidemia, were included in the study.
View Article and Find Full Text PDFVaccines (Basel)
November 2024
Women's and Children's Health Network, North Adelaide, SA 5006, Australia.
Background/objectives: Influenza vaccination is recommended for pregnant women, offering the dual benefit of protecting pregnant women and their newborn infants against influenza. This study aimed to investigate the impact of body mass index (BMI) on influenza vaccine responses in pregnant women and their newborns.
Methods: Participants included pregnant women attending the Women's and Children's Hospital in South Australia between 2018 and 2021.
Sensors (Basel)
December 2024
National Institute of Physical Education of Catalonia (INEFC), 08038 Barcelona, Spain.
Several microtechnology devices quantify the external load of team sports using Global Positioning Systems sampling at 5, 10, or 15 Hz. However, for short, explosive actions, such as collisions, these sample rates may be limiting. It is known that very high-frequency sampling is capable of capturing changes in actions over a short period of time.
View Article and Find Full Text PDFSensors (Basel)
December 2024
Applied Biomechanics and Sport Technology Research Group, Autonomous University of Madrid, 28049 Madrid, Spain.
The countermovement jump (CMJ) is a widely used test to assess lower body neuromuscular performance. This study aims to analyze the validity and reliability of an iOS application using artificial intelligence to measure CMJ height, force, velocity, and power in unloaded and loaded conditions. Twelve physically active participants performed 12 CMJs with external loads ranging from 0% to 70% of their body mass while being simultaneously monitored with a pair of force platforms and the My Jump Lab application.
View Article and Find Full Text PDFPharmaceutics
November 2024
Department of Pharmacy Practice, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA.
Gabapentin has variable pharmacokinetics (PK), which contributes to difficulty in dosing and increased risk of adverse events. The objective of this study was to leverage gabapentin concentrations from therapeutic drug monitoring (TDM) to develop a population PK (popPK) model and characterize significant covariates that impact gabapentin PK. Data were retrospectively collected from 82 hospitalized adult patients with TDM gabapentin concentrations.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!